Shares of Qiagen have rebounded after three years following a news report that the provider of biotech workflow solutions was evaluating strategic options, which include a potential sale.

Abbott Laboratories' January price pullback is a signal to load up on shares; this Dividend Aristocrat is growing its ...

The agency cleared lab-based and point-of-care infectious disease and clinical chemistry tests as well as software for digital pathology.

NEW YORK — The US Food and Drug Administration has issued warning letters to four direct-to-consumer health testing companies for selling unauthorized blood collection kits for HIV diagnosis.

The FDA has authorized the first at-home testing kits for gonorrhea, chlamydia, and trichomoniasis, along with new gonorrhea ...

Dr. Daniel Jernigan, former director of the CDC’s National Center for Emerging and Zoonotic Infectious Diseases, calls the ...

New options for testing and treating some of the most common sexually transmitted diseases are becoming available.

COVID-19 infections are rising across the United States, amid surges in other winter illnesses. The uptick in COVID comes as the country faces a severe flu season and outbreaks of norovirus, which are ...

For ecologists, the Covid-19 pandemic has presented a remarkable natural experiment in what can happen to wild animals when humans stay home. By Emily Anthes About two decades ago, the dark-eyed junco ...

STATEN ISLAND, N.Y. — With the terrifying coronavirus (COVID-19) pandemic of 2020 behind us and the world now returned to normal, many people have moved away from vaccination or even testing for the ...

Pandemic preparedness kit reviewed with COVID-19 essential items. President Trump signs executive order reclassifying marijuana Taylor Swift's Christmas card is here—and this is what it looks like 77 ...

Abbott said on Thursday it would buy cancer test maker Exact Sciences in an up to $23 billion deal, bolstering the medical device maker's diagnostics business. This marks one of Abbott's largest deals ...